Loading clinical trials...
Loading clinical trials...
The main limitation patients with orthostatic intolerance (OI, or postural tachycardia syndrome, POTS) have to exercise is related to their increase in heart rate when standing. Main pharmacological t...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Vanderbilt University
NCT00409435 · Postural Tachycardia Syndrome
NCT07189936 · Post-Acute COVID-19 Syndrome, Postural Tachycardia Syndrome (POTS), and more
NCT05421208 · Post-acute COVID-19 Syndrome, Postural Tachycardia Syndrome (POTS), and more
NCT05375968 · Postural Tachycardia Syndrome (POTS)
NCT05107635 · Inappropriate Sinus Tachycardia, Postural Tachycardia Syndrome
Vanderbilt University Medical Center
Nashville, Tennessee
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions